help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiorelli, G.
Right arrow Articles by Serio, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiorelli, G.
Right arrow Articles by Serio, M.

Journal of Clinical Endocrinology & Metabolism, Vol 72, 740-746, Copyright © 1991 by Endocrine Society


ARTICLES

Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog

G Fiorelli, A De Bellis, A Longo, S Giannini, A Natali, A Costantini, GB Vannelli and M Serio
Department of Clinical Physiopathology, University of Florence, Italy.

Insulin-like growth factor I (IGF-I) receptors were characterized in membranes obtained from prostate tissue of patients affected by benign prostatic hyperplasia (BPH) before and after treatment with a GnRH agonist analog. Binding of [125I]IGF-I to membranes obtained from untreated patients was specific and time and temperature dependent. Analysis of the binding data yielded two classes of binding sites, one of high affinity (Kd, 10(-11) mol/L) and one of lower affinity (Kd, 10(- 9) mol/L). BPH membrane preparations were affinity-cross linked to labeled IGF-I, and then subjected to sodium dodecyl sulfate- polyacrylamide gel electrophoresis. Analysis by autoradiography revealed one labeled protein with an apparent Mr = 300K under nonreducing conditions and two labeled protein with Mr = 270K and Mr = 130K under reducing conditions. Excess unlabeled IGF-II reduce both of them, whereas the same excess of IGF-I completely abolished them. In membrane preparations of prostatic tissues from patients affected by BPH and treated for 2 months with a GnRH agonist analog, the binding capacities of both binding sites were significantly higher than those of BPH tissue from untreated patients, whereas binding affinities were unchanged. The IGF-I receptor in BPH prostate tissue of untreated patients was mainly localized in the basal layer of the epithelium, as demonstrated by immunohistochemical staining, whereas in the tissue from treated patients positive staining was found also in the glandular epithelium. These results demonstrate that: 1) specific binding sites for IGF-I are present in prostatic tissue from patients with BPH, 2) androgen deprivation increases their binding capacities and seems to modify their epithelial localization.


This article has been cited by other articles:


Home page
CarcinogenesisHome page
J. Fang, Q. Zhou, X.-l. Shi, and B.-h. Jiang
Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells
Carcinogenesis, March 1, 2007; 28(3): 713 - 723.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Colao, C. Di Somma, S. Spiezia, M. Filippella, R. Pivonello, and G. Lombardi
Effect of Growth Hormone (GH) and/or Testosterone Replacement on the Prostate in GH-Deficient Adult Patients
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 88 - 94.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S.-F. Wu, H.-Z. Sun, X.-D. Qi, and Z.-H. Tu
Effect of Epristeride on the Expression of IGF-1 and TGF-{beta} Receptors in Androgen-Induced Castrated Rat Prostate
Experimental Biology and Medicine, November 1, 2001; 226(10): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Harman, E. J. Metter, M. R. Blackman, P. K. Landis, and H. B. Carter
Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4258 - 4265.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
F. Gori, L. C. Hofbauer, C. A. Conover, and S. Khosla
Effects of Androgens on the Insulin-Like Growth Factor System in an Androgen-Responsive Human Osteoblastic Cell Line
Endocrinology, December 1, 1999; 140(12): 5579 - 5586.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. W. Gregory, D. Kim, P. Ye, A. J. D’Ercole, T. G. Pretlow, J. L. Mohler, and F. S. French
Androgen Receptor Up-Regulates Insulin-Like Growth Factor Binding Protein-5 (IGFBP-5) Expression in a Human Prostate Cancer Xenograft
Endocrinology, May 1, 1999; 140(5): 2372 - 2381.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. E. Damon, L. Maddison, J. L. Ware, and S. R. Plymate
Overexpression of an Inhibitory Insulin-Like Growth Factor Binding Protein (IGFBP), IGFBP-4, Delays Onset of Prostate Tumor Formation
Endocrinology, August 1, 1998; 139(8): 3456 - 3464.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. De Bellis, C. Crescioli, C. Grappone, S. Milani, P. Ghiandi, G. Forti, and M. Serio
Expression and Cellular Localization of Keratinocyte Growth Factor and Its Receptor in Human Hyperplastic Prostate Tissue
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2186 - 2191.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society